RPG Life Sciences Ltd.

Financial

	RPG Life Sciences	Sequent Scientific	Gufic Biosciences
Operational Metrics
Pharmaceutical Sector
Domestic Sales Growth - YoY	-11.18 %	n/a	n/a
R&D as a % of Total Sales	1.5 %	0.0	0.83 %
Financials
5 yr Average ROE	20.08 %	1.28 %	25.05 %
5yr average Equity Multiplier	1.4	2.12	2.22
5yr Average Asset Turnover Ratio	1.26	0.92	1.05
5yr Avg Net Profit Margin	11.59 %	0.94 %	10.9 %
Price to Book	10.1	5.67	6.71
P/E	48.44	330.58	46.99
5yr Avg Cash Conversion Cycle	-64.92 Days	55.84 Days	26.94 Days
Inventory Days	63.34 Days	76.26 Days	66.86 Days
Days Receivable	25.32 Days	87.51 Days	128.09 Days
Days Payable	145.09 Days	117.98 Days	163.91 Days
5yr Average Interest Coverage Ratio	17.66	2.31	13.1
5yr Avg ROCE	27.52 %	7.29 %	27.25 %
5yr Avg Operating Profit Margin	19.26 %	8.58 %	18.45 %
5 yr average Debt to Equity	0.02	0.5	0.51
5yr CAGR Net Profit	24.75 %	n/a	14.26 %
5yr Average Return on Assets	14.44 %	0.71 %	11.52 %
Shareholdings
Promoter Holding	72.95 %	52.61 %	72.51 %
Share Pledged by Promoters	0.0	0.0	0.0
Change in Promoter Holding (3 Yrs)	0.88 %	-0.41 %	-2.97 %
Change in Mutual Fund Holding (3 Yrs)	3.53 %	9.92 %	2.36 %

Business

	RPG Life Sciences	Sequent Scientific	Gufic Biosciences
Product Wise Break-Up	Product Wise Break-Up Domestic Formulations 66.0 International formulations 19.0 Active Pharmaceutical Ingredient (API) 15.0 Active Pharmaceutical Ingredient 0 Formulations 0 API 0 Muscle Relaxants 0 Cardiovascular 0 Proton pump inhibitors 0 Anti-fungals 0 Anti-bacterials 0 International 0 CMO 0 Domestic 0	Product Wise Break-Up Anti-bacterials 0 Formulations 78.27 API 0 Cardiovascular 0 Domestic 0 International 0 Active Pharmaceutical Ingredient (API) 0 International formulations 0 Muscle Relaxants 0 Active Pharmaceutical Ingredient (API) 21.13 Proton pump inhibitors 0 Anti-fungals 0 Domestic Formulations 0 CMO 0 Others 0.6	Product Wise Break-Up Anti-bacterials 0 Formulations 0 Active Pharmaceutical Ingredient (API) 5.0 Cardiovascular 0 Domestic Pharmaceuticals 50.0 International 15.0 Active Pharmaceutical Ingredient (API) 0 International formulations 0 Muscle Relaxants 0 Active Pharmaceutical Ingredient 0 Proton pump inhibitors 0 Anti-fungals 0 Domestic Formulations 0 CMO 30.0
Location Wise Break-Up	Location Wise Break-Up India 66.55 Rest of the World 33.45 Turkey 0 LATAM 0 EM 0 Asia 0 Europe 0 South America 0 Australia 0 North America 0 Africa 0	Location Wise Break-Up Rest of the World 34.17 North America 0 LATAM 0 Africa 0 Turkey 0 Australia 0 South America 0 India 0 Europe 41.73 Asia Pacific 24.1 EM 0	Location Wise Break-Up Rest of the World 0 North America 1.27 LATAM 0 Africa 0.72 Turkey 0 Australia 0.53 South America 0.23 India 89.07 Europe 3.67 Asia Pacific 4.5 EM 0 Others 0.01
Therapeutic Area Break-Up	Therapeutic Area Break-Up urology 0 oncology 0 respiratory 0 neuro 0 Gastro intestinal 0 Orthopedics 0 Nephrology 0 Cardio 0 Nutritional 0 Pain management 0 Anthelmintics 0 Antibiotic Injectables 0 Antibiotic Non-Injectables 0 Others 100	Therapeutic Area Break-Up Gastro intestinal 0 Cardio 0 Antibiotic Injectables 33.0 urology 0 respiratory 0 Antibiotic Non-Injectables 15.0 Pain management 0 Nephrology 0 neuro 0 Nutritional 0 Anthelmintics 11.0 Orthopedics 0 oncology 0 Others 41.0	-

RPG Life Sciences Ltd.

SIGN UP FOR FREE